正天丸联合西药治疗偏头痛的疗效及对血管源性活性介质的调节作用
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R747.2

基金项目:

河南省科技攻关项目(192102310436)


Curative Effect of Zhengtian Pills Combined with Western Medicine for Migraine and Its Regulatory Effect on Vasogenic Activity Mediators
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察正天丸联合西药治疗偏头痛瘀阻脑络证的临床疗效及对血管源性活性介质的调节作用。方法:将 100 例符合要求的患者按随机数字表法分成对照组和观察组各 50 例。2 组患者在发作期均予对乙酰氨基酚片治疗,疼痛不能控制者加用佐米曲普坦片,症状缓解后停用;缓解期口服盐酸氟桂利嗪胶囊,连续治疗 8 周。观察组加服正天丸,连续治疗 8 周。记录治疗前后的头痛发作次数,评价头痛程度评分、头痛持续时间评分及偏头痛特异性生活质量量表(MSQ)评分,治疗前后检测一氧化氮(NO)、内皮素 1(ET-1)、降钙素基因相关肽(CGRP)及 6-酮-前列腺素 F1α(6-keto-PGF1α)等血管源性活性因子。比较2 组的临床疗效。结果:治疗后,观察组临床疗效优于对照组(P<0.05)。2 组头痛发作次数、头痛程度评分及持续时间评分与治疗前比较均减少或降低(P<0.01);观察组头痛发作次数少于对照组(P<0.01),头痛程度评分及持续时间评分均低于对照组(P<0.01)。2 组 MSQ 的角色限制维度 (RR)、角色妨碍维度 (RP) 及情感功能维度 (EF) 评分与治疗前比较均较治疗前升高(P<0.01),观察组 3 项维度的评分均高于对照组(P<0.01)。2 组 NO 水平均较治疗前升高(P<0.01),6-keto-PGF1α、CGRP、ET-1 水平均较治疗前降低 (P<0.01);观察组 NO 水平高于对照组 (P<0.01),6-keto-PGF1α、CGRP、ET-1 水平均低于对照组(P<0.01)。结论:正天丸配合常规西药治疗,可显著改善偏头痛的发作情况,提高患者的生活质量,其可能通过调节血管活性介质,纠正患者的血管舒缩功能失调状态,从而发挥治疗作用。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Zhengtian pills combined with western medicine for migraine with stasis obstructing the brain collateral syndrome and its regulatory effect on vasogenic activity mediators. Methods:A total of 100 cases of patients who met requirements were divided into the control group and the observation group according to the random number table method,50 cases in each group. In attack period,both groups were given paracetamol tablets,for those patients whose pain could not be relieved,they were additionally given the oral administration of zolmitriptan tablets, and treatment was discontinued after symptom remission; in remission period, they were treated with the oral administration of flunarizine hydrochloride capsules for eight weeks. The observation group was additionally given the oral administration of Zhengtian pills with eight- week continuous treatment. The seizure times of headache before and after treatment were recorded. The scores of the degree and duration of headache,as well as the scores of Migraine- Specific Quality-of-Life Questionnaire(MSQ) were evaluated. The levels of nitric oxide(NO),endothelin-1(ET-1),calcitonin generelated peptid(CGRP), 6- keto- prostaglandin F1α(6- keto- PGF1α) and other vasogenic activity factors before and after treatment were evaluated. The clinical effect was compared between the two groups. Results:After treatment,the clinical effect in the observation group was better than that in the control group(P<0.05). In the two groups,the seizure times of headache were reduced when compared with those before treatment(P<0.01),and the scores of the degree and duration of headache were decreased(P<0.01). The seizure times of headache in the observation group were less than those in the control group(P<0.01),and the scores of the degree and duration of headache were lower(P<0.01). In the two groups,the scores of role restrictive dimension(RR), role preventive dimension(RP), and dimension of emotional function(EF) were increased when compared with those before treatment(P<0.01),and the scores of the three dimensions in the observation group were higher than those in the control group(P<0.01). In the two groups, the levels of NO were increased when compared with those before treatment(P<0.01),and the levels of 6-keto-PGF1α,CGRP,and ET-1 were decreased(P< 0.01). The level of NO in the observation group was higher than that in the control group(P<0.01),and the levels of 6-ketoPGF1α, CGRP,and ET-1 were lower(P<0.01). Conclusion:The therapy of Zhengtian pills combined with routine western medicine can significantly improve seizure of migraine and improve quality of life of patients. It probably plays a therapeutic role by regulating vasoactive mediators and correcting maladjustment of vascular contractile and diastolic function.

    参考文献
    相似文献
    引证文献
引用本文

沈雷,张保朝,傅国惠,白方会,曹杏,梁燕.正天丸联合西药治疗偏头痛的疗效及对血管源性活性介质的调节作用[J].新中医,2021,53(1):57-60

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-01-11
  • 出版日期:
文章二维码